CONTEXT: Total hip arthroplasty is a common surgical procedure but little is known about longitudinal trends. OBJECTIVE: To examine demographics and outcomes of patients undergoing primary and revision total hip arthroplasty. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort of 1,453,493 Medicare Part A beneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision total hip arthroplasty. Participants were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes for primary and revision total hip arthroplasty between 1991 and 2008. MAIN OUTCOME MEASURES: Changes in patient demographics and comorbidity, hospital length of stay (LOS), mortality, discharge disposition, and all-cause readmission rates. RESULTS: Between 1991 and 2008, the mean age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001). The mean number of comorbid illnesses per patient increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001). For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days in 1991-1992 to 3.7 days in 2007-2008 (P = .002); unadjusted in-hospital and 30-day mortality decreased from 0.5% to 0.2% and from 0.7% to 0.4%, respectively (P < .001). The proportion of primary total hip arthroplasty patients discharged home declined from 68.0% to 48.2%; the proportion discharged to skilled care increased from 17.8% to 34.3%; and 30-day all-cause readmission increased from 5.9% to 8.5% (P < .001). For revision total hip arthroplasty, similar trends were observed in hospital LOS, in-hospital mortality, discharge disposition, and hospital readmission rates. CONCLUSION: Among Medicare beneficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease in hospital LOS but an increase in the rates of discharge to postacute care and readmission.
CONTEXT: Total hip arthroplasty is a common surgical procedure but little is known about longitudinal trends. OBJECTIVE: To examine demographics and outcomes of patients undergoing primary and revision total hip arthroplasty. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort of 1,453,493 Medicare Part A beneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision total hip arthroplasty. Participants were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes for primary and revision total hip arthroplasty between 1991 and 2008. MAIN OUTCOME MEASURES: Changes in patient demographics and comorbidity, hospital length of stay (LOS), mortality, discharge disposition, and all-cause readmission rates. RESULTS: Between 1991 and 2008, the mean age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001). The mean number of comorbid illnesses per patient increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001). For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days in 1991-1992 to 3.7 days in 2007-2008 (P = .002); unadjusted in-hospital and 30-day mortality decreased from 0.5% to 0.2% and from 0.7% to 0.4%, respectively (P < .001). The proportion of primary total hip arthroplastypatients discharged home declined from 68.0% to 48.2%; the proportion discharged to skilled care increased from 17.8% to 34.3%; and 30-day all-cause readmission increased from 5.9% to 8.5% (P < .001). For revision total hip arthroplasty, similar trends were observed in hospital LOS, in-hospital mortality, discharge disposition, and hospital readmission rates. CONCLUSION: Among Medicare beneficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease in hospital LOS but an increase in the rates of discharge to postacute care and readmission.
Authors: Leslie R M Hausmann; Maria Mor; Barbara H Hanusa; Susan Zickmund; Peter Z Cohen; Richard Grant; Denise M Kresevic; Howard S Gordon; Bruce S Ling; C Kent Kwoh; Said A Ibrahim Journal: J Gen Intern Med Date: 2010-05-28 Impact factor: 5.128
Authors: Agustín Escalante; Jane Barrett; Inmaculada del Rincón; John E Cornell; Charlotte B Phillips; Jeffrey N Katz Journal: Med Care Date: 2002-06 Impact factor: 2.983
Authors: J N Katz; E Losina; J Barrett; C B Phillips; N N Mahomed; R A Lew; E Guadagnoli; W H Harris; R Poss; J A Baron Journal: J Bone Joint Surg Am Date: 2001-11 Impact factor: 5.284
Authors: Jeffrey N Katz; Charlotte B Phillips; John A Baron; Anne H Fossel; Nizar N Mahomed; Jane Barrett; Elizabeth A Lingard; William H Harris; Robert Poss; Robert A Lew; Edward Guadagnoli; Elizabeth A Wright; Elena Losina Journal: Arthritis Rheum Date: 2003-02
Authors: Michael P Cary; Victoria Goode; Nancy Crego; Deirdre Thornlow; Cathleen S Colón-Emeric; Helen M Hoenig; Kayla Baba; Scarlet Fellingham; Elizabeth I Merwin Journal: Arch Phys Med Rehabil Date: 2018-01-31 Impact factor: 3.966
Authors: Elizabeth W Paxton; Maria C S Inacio; Jasvinder A Singh; Rebecca Love; Stefano A Bini; Robert S Namba Journal: Clin Orthop Relat Res Date: 2015-11 Impact factor: 4.176
Authors: Denis Nam; Anita Sadhu; Jeffrey Hirsh; James A Keeney; Ryan M Nunley; Robert L Barrack Journal: J Arthroplasty Date: 2014-09-06 Impact factor: 4.757
Authors: Douglas S Weinberg; Matthew J Kraay; Steven J Fitzgerald; Vasu Sidagam; Glenn D Wera Journal: Clin Orthop Relat Res Date: 2016-11-11 Impact factor: 4.176